A majority of patients in a small clinical trial have been in remission from a deadly type of cancer for more than four years.
Attorneys in a dispute over CRISPR gene-editing make their case to patent judges.
People voice concerns about drugs via search queries—and that data that can predict when one might be recalled.
Many genetic conditions come with clues in a person’s face, and new technology can help doctors diagnose them.
Synthetic biologists seek to make perfumes from extinct trees and flowers.
DARPA scientists think they can use insects to deliver genetic changes to crops.
The clampdown will clean up the air and help spur electric vehicle adoption.
Companies are racing to develop a new type of cancer therapy, but scientists are still assessing its safety.
Using 30 percent less energy and scrapping coal subsidies are a far cry from America’s likely future environmental policies.
By 2030, we may be gobbling turkey meat grown in bioreactors.